Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events

Daniala L Weir, Todd C Lee, Emily G McDonald, Aude Motulsky, Michal Abrahamowicz, Steven Morgan, David Buckeridge, Robyn Tamblyn, Daniala L Weir, Todd C Lee, Emily G McDonald, Aude Motulsky, Michal Abrahamowicz, Steven Morgan, David Buckeridge, Robyn Tamblyn

Abstract

Background: Admission to hospital provides the opportunity to review patient medications; however, the extent to which the safety of drug regimens changes after hospitalization is unclear.

Objective: To estimate the number of potentially inappropriate medications (PIMs) prescribed to patients at hospital discharge and their association with the risk of adverse events 30 days after discharge.

Design: Prospective cohort study.

Setting: Tertiary care hospitals within the McGill University Health Centre Network in Montreal, Quebec, Canada.

Participants: Patients from internal medicine, cardiac, and thoracic surgery, aged 65 years and older, admitted between October 2014 and November 2016.

Measures: Abstracted chart data were linked to provincial health databases. PIMs were identified using AGS (American Geriatrics Society) Beers Criteria®, STOPP, and Choosing Wisely statements. Multivariable logistic regression and Cox models were used to assess the association between PIMs and adverse events.

Results: Of 2,402 included patients, 1,381 (57%) were male; median age was 76 years (interquartile range [IQR] = 70-82 years); and eight discharge medications were prescribed (IQR = 2-8). A total of 1,576 (66%) patients were prescribed at least one PIM at discharge; 1,176 (49%) continued a PIM from prior to admission, and 755 (31%) were prescribed at least one new PIM. In the 30 days after discharge, 218 (9%) experienced an adverse drug event (ADE) and 862 (36%) visited the emergency department (ED), were rehospitalized, or died. After adjustment, each additional new PIM and continued community PIM were respectively associated with a 21% (odds ratio [OR] = 1.21; 95% confidence interval [CI] = 1.01-1.45) and a 10% (OR = 1.10; 95% CI = 1.01-1.21) increased odds of ADEs. They were also respectively associated with a 13% (hazard ratio [HR] = 1.13; 95% CI = 1.03-1.26) and a 5% (HR = 1.05; 95% CI = 1.00-1.10) increased risk of ED visits, rehospitalization, and death.

Conclusions: Two in three hospitalized patients were prescribed a PIM at discharge, and increasing numbers of PIMs were associated with an increased risk of ADEs and all-cause adverse events. Improving hospital prescribing practices may reduce the frequency of PIMs and associated adverse events. J Am Geriatr Soc 68:1184-1192, 2020.

Keywords: adverse drug events; hospital discharge; potentially inappropriate medications.

Conflict of interest statement

Drs McDonald and Lee own the intellectual property rights to MedSafer in conjunction with McGill University.

© 2020 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals, Inc. on behalf of The American Geriatrics Society.

Figures

Figure 1
Figure 1
Flowchart of patient exclusions. MGH, Montreal General Hospital; RAMQ, Regiel'assurance maladie; RVH, Royal Victoria Hospital; Rx, prescription.
Figure 2
Figure 2
Classification of medications prescribed at discharge. PIM indicates potentially inappropriate medication.

References

    1. Amann U, Schmedt N, Garbe E. Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list. Dtsch Ärztebl Int. 2012;109:69.
    1. Rothberg MB, Pekow PS, Liu F, et al. Potentially inappropriate medication use in hospitalized elders. J Hosp Med. 2008;3:91‐102.
    1. Poudel A, Peel NM, Nissen L, Mitchell C, Gray LC, Hubbard RE. Potentially inappropriate prescribing in older patients discharged from acute care hospitals to residential aged care facilities. Ann Pharmacother. 2014;48:1425‐1433.
    1. Morgan SG, Hunt J, Rioux J, Proulx J, Weymann D, Tannenbaum C. Frequency and cost of potentially inappropriate prescribing for older adults: a cross‐sectional study. CMAJ Open. 2016;4:E346‐E351.
    1. Laroche M‐L, Charmes J‐P, Nouaille Y, Fourrier A, Merle L. Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging. 2006;23:49‐59.
    1. Komagamine J. Prevalence of potentially inappropriate medications at admission and discharge among hospitalised elderly patients with acute medical illness at a single centre in Japan: a retrospective cross‐sectional study. BMJ Open. 2018;8:e021152.
    1. Clyne B, Smith SM, Hughes CM, et al. Sustained effectiveness of a multifaceted intervention to reduce potentially inappropriate prescribing in older patients in primary care (OPTI‐SCRIPT study). Implement Sci. 2016;2:11‐79.
    1. Chen Y‐C, Hwang S‐J, Lai H‐Y, et al. Potentially inappropriate medication for emergency department visits by elderly patients in Taiwan. Pharmacoepidemiol Drug Saf. 2009;18:53‐61.
    1. Pérez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ. 2018;363:k4524.
    1. Van Der Stelt CA, Windsant‐van den Tweel AV, Egberts AC, et al. The association between potentially inappropriate prescribing and medication‐related hospital admissions in older patients: a nested case control study. Drug Saf. 2016;39:79‐87.
    1. Tosato M, Landi F, Martone AM, et al. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43:767‐773.
    1. Moriarty F, Bennett K, Cahir C, Kenny RA, Fahey T. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community‐dwelling older people: a prospective cohort study: potentially inappropriate prescribing and adverse outcomes in older people. Br J Clin Pharmacol. 2016;82:849‐857.
    1. Lau DT, Kasper JD, Potter DEB, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165:68‐74.
    1. Hamilton H, Gallagher P, Ryan C, Byrne S, OʼMahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171:1013‐1019.
    1. Hill‐Taylor B, Sketris I, Hayden J, Byrne S, OʼSullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38:360‐372.
    1. Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A. How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2012;2:e001461.
    1. Cochrane RA, Mandal AR, Ledger‐Scott M, Walker R. Changes in drug treatment after discharge from hospital in geriatric patients. BMJ. 1992;305:694‐696.
    1. Harris CM, Sridharan A, Landis R, Howell E, Wright S. What happens to the medication regimens of older adults during and after an acute hospitalization? J Patient Saf. 2013;9:150‐153.
    1. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20:317‐323.
    1. Van Craen K, Braes T, Wellens N, et al. The effectiveness of inpatient geriatric evaluation and management units: a systematic review and meta‐analysis. J Am Geriatr Soc. 2010;58:83‐92.
    1. Renaudin P, Boyer L, Esteve M‐A, Bertault‐Peres P, Auquier P, Honore S. Do pharmacist‐led medication reviews in hospitals help reduce hospital readmissions? a systematic review and meta‐analysis. Br J Clin Pharmacol. 2016;82:1660‐1673.
    1. Bullock B, Donovan P, Mitchell C, Whitty JA, Coombes I. The impact of a pharmacist on post‐take ward round prescribing and medication appropriateness. Int J Clin Pharmacol. 2019;41:65‐73.
    1. Ravn‐Nielsen LV, Duckert M‐L, Lund ML, et al. Effect of an in‐hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med. 2018;178:375‐382.
    1. Tamblyn R, Huang AR, Meguerditchian AN, et al. Using novel Canadian resources to improve medication reconciliation at discharge: study protocol for a randomized controlled trial. Trials. 2012;13:150.
    1. Tamblyn R, Winslade N, Lee TC, et al. Improving patient safety and efficiency of medication reconciliation through the development and adoption of a computer‐assisted tool with automated electronic integration of population‐based community drug data: the RightRx project. J Am Med Inform Assoc. 2018;25:482‐495.
    1. Prescription Drug Insurance | RAMQ [Internet]. . Accessed February 15, 2019.
    1. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995;48:999‐1009.
    1. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57:131‐141.
    1. Tamblyn R, Eguale T, Huang A, Winslade N, Doran P. The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study. Ann Intern Med. 2014;160:441‐450.
    1. Tamblyn R, Poissant L, Huang A, et al. Estimating the information gap between emergency department records of community medication compared to on‐line access to the community‐based pharmacy records. J Am Med Inform Assoc. 2014;21:391‐398.
    1. Mitchell AS, Henry DA, Hennrikus D, OʼConnell DL. Adverse drug reactions: can consumers provide early warning? Pharmacoepidemiol Drug Saf. 1994;3:257‐264.
    1. OʼMahony D, OʼSullivan D, Byrne S, OʼConnor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213‐218.
    1. By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel . American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227‐2246.
    1. Choosing Wisely . Choosing Wisely Canada Recommendations [Internet]. 2018. . Accessed December 2017.
    1. EG MD, Wu PE, Rashidi B, et al. The MedSafer study: a controlled trial of an electronic decision support tool for deprescribing in acute care. J Am Geriatr Soc. 2019;67(9):1843‐1850.
    1. Weir DL. Medications Prescribed, Stopped and Modified at Hospital Discharge and Filled Medications in the Community: Factors Associated With Failure to Follow Hospital Medication Changes 30‐Days Post Discharge. Toronto: Canadian Association for Health Services and Policy Research Conference; 2017.
    1. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA. 1995;274:35‐43.
    1. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29‐34.
    1. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinicianʼs guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795.
    1. Lapointe‐Shaw L, Austin PC, Ivers NM, Luo J, Redelmeier DA, Bell CM. Death and readmissions after hospital discharge during the December holiday period: cohort study. BMJ. 2018;363:k4481.
    1. Afshartous D, Preston RA. Key results of interaction models with centering. J Stat Educ. 2011;19 10.1080/10691898.2011.11889620.
    1. Aguinis H, Gottfredson RK. Best‐practice recommendations for estimating interaction effects using moderated multiple regression. J Organ Behav. 2010;31:776‐786.
    1. Gutiérrez‐Valencia M, Izquierdo M, Malafarina V, et al. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: a retrospective study. Geriatr Gerontol Int. 2017;17:2354‐2360.
    1. Pardo‐Cabello AJ, Manzano‐Gamero V, Zamora‐Pasadas M, Gutiérrez‐Cabello F, Esteva‐Fernández D, Luna‐Del Castillo J de D, Jiménez‐Alonso J. Potentially inappropriate prescribing according to STOPP‐2 criteria among patients discharged from internal medicine: prevalence, involved drugs and economic cost. Arch Gerontol Geriatr. 2018;74:150–154.
    1. Wauters M, Elseviers M, Vaes B, et al. Too many, too few, or too unsafe? impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community‐dwelling oldest old. Br J Clin Pharmacol. 2016;82:1382‐1392.
    1. Britten N, Brant S, Cairns A, et al. Continued prescribing of inappropriate drugs in general practice. J Clin Pharm Ther. 1995;20:199‐205.
    1. Moen J, Norrgård S, Antonov K, Nilsson JLG, Ring L. GPsʼ perceptions of multiple‐medicine use in older patients. J Eval Clin Pract. 2010;16:69‐75.
    1. Schuling J, Gebben H, Veehof LJG, Haaijer‐Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs: a qualitative study. BMC Fam Pract. 2012;13:1.
    1. Iliffe S, Curran HV, Collins R, Yuen Kee SC, Fletcher S, Woods B. Attitudes to long‐term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health. 2004;8:242‐248.
    1. Dickinson R, Knapp P, House AO, et al. Long‐term prescribing of antidepressants in the older population: a qualitative study. Br J Gen Pract. 2010;60:144‐155.
    1. Bell CM, Fischer HD, Gill SS, et al. Initiation of benzodiazepines in the elderly after hospitalization. J Gen Intern Med. 2007;22:1024‐1029.
    1. Villamañán E, Ruano M, Lara C, et al. Reasons for initiation of proton pump inhibitor therapy for hospitalised patients and its impact on outpatient prescription in primary care. Rev Esp Enferm Dig. 2015;107:652‐658.
    1. Lee TC, Desforges P, Murray J, Saleh RR, McDonald EG. Off‐label use of quetiapine in medical inpatients and postdischarge. JAMA Intern Med. 2016;176:1390‐1391.
    1. Reducing Post‐Discharge Potentially Inappropriate Medications Among Older Adults ‐ Full Text View ‐ [Internet]. . Accessed November 18, 2019.
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487‐497.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir